Feyza Gül Özbay Kurt

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice

Rebekka Bitsch, Annina Kurzay, Feyza Gül Özbay Kurt et al. · Journal for ImmunoTherapy of Cancer · 2022 · 84 citations · Full text

Medicine, Immunology, Oncology +16

Identification of circulating MOG-specific B cells in patients with MOG antibodies

Stephan Winklmeier, Miriam Schlüter, Melania Spadaro et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 65 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

Feyza Gül Özbay Kurt, Alisa Lepper, Catharina Gerhards et al. · Frontiers in Immunology · 2022 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme

Özgün SAYINER, Sema Arısoy, Tansel Çomoğlu et al. · Journal of Drug Delivery Science and Technology · 2020 · 42 citations

Pharmacy, Biomedical Engineering, Oncology +17

Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes

M. Alper Kursunel, Ekim Z. Taşkıran, Ece Tavukçuoğlu et al. · Cancer Immunology Immunotherapy · 2021 · 41 citations · Full text

Life Sciences, Cell Biology, Oncology +17